Sigma inks licensing deal with Alnylam

RNA interference is a naturally occurring mechanism within cells for selectively silencing and regulating specific genes. Since many diseases are caused by the inappropriate activity of specific genes, the ability to silence and regulate such genes selectively through RNAi could provide a means to treat a wide range of human diseases, the companies said.

Sigma-Aldrich said the license agreement further strengthens Sigma's position as a key licensed supplier of

Sigma inks licensing deal with Alnylam

BioBOOM Op/Ed: Alnylam continues to sign lic agreements with the big boys. Check them out, we did and bought. They also have a relationship with Ambion.

No comments:

Blog Archive